Collegium Pharmaceutical (COLL) Change in Inventory (2016 - 2026)

Collegium Pharmaceutical has reported Change in Inventory for 11 years, with the latest figure at $597000.0 in Q2 2026.

• On a quarterly basis, Change in Inventory fell 35.81% year-over-year to $597000.0 in Q2 2026; TTM through Jun 2026 was $5.2 million, a 175.57% increase from a year earlier, with the FY2025 full-year figure at $5.4 million, up 138.44% from the prior year.
• Change in Inventory was $597000.0 for Q2 2026 at Collegium Pharmaceutical, down from $1.8 million in the prior quarter.
• The five-year high for Change in Inventory was $8.1 million in Q3 2023, with the low at -$18.2 million in Q4 2022.
• Average Change in Inventory over 5 years is -$3.8 million, with a median of -$1.4 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: Change in Inventory slumped 50516.67% in 2022, then soared 257.01% in 2025.
• Over 5 years, Change in Inventory stood at -$18.2 million in 2022, then jumped by 90.12% to -$1.8 million in 2023, then slumped by 37.87% to -$2.5 million in 2024, then soared by 215.74% to $2.9 million in 2025, then tumbled by 79.13% to $597000.0 in 2026.
• The last three Change in Inventory figures came in at $597000.0 (Q2 2026), $1.8 million (Q1 2026), and $2.9 million (Q4 2025), per Business Quant data.